- Sight Sciences, Inc. is an eyecare technology company focused on developing innovative interventional technologies for glaucoma and dry eye disease, currently positioned in the medical devices market with a total revenue of $77.4 million for 2025.
- In March 2026, Sight Sciences reported a 7% increase in fourth quarter revenue compared to the previous year and initiated financial guidance for 2026, while also achieving a gross margin of 87%.
- The company recently secured a court ruling that awarded them over $34 million in damages against Alcon for patent infringement related to their Hydrus® Microstent, highlighting their commitment to protecting their intellectual property.
- Sight Sciences' ideal buyers are ophthalmologists and healthcare providers looking for advanced solutions to manage glaucoma and dry eye disease, addressing the need for effective and innovative treatment options in these areas.
Sales and Support is the largest functional group at Sight Sciences, accounting for more than one-third of all employees. Business Management and Healthcare roles follow, together representing nearly a quarter of the organization’s headcount. Engineering, Finance and Administration, and Marketing and Product teams are similar in size, highlighting an even distribution of technical, financial, and go-to-market resources. Smaller yet essential groups include Operations, Human Resources, and Information Technology, each supporting day-to-day efficiency across the company.
Sight Sciences’ workforce is widely distributed, with the greatest concentration of employees classified under “Other” locations—an indication of a sizeable field or remote presence. The San Francisco Bay Area, close to the company’s headquarters, hosts the largest single-city contingent. Additional clusters are based in Chicago, Dallas, San Jose, Houston, and several mid-sized metropolitan areas such as Minneapolis, Los Angeles, Sacramento, and St. Louis, reflecting the company’s nationwide reach in sales, clinical support, and corporate functions.
